Comprehensive Guide to Hydration Disorders and Sodium Imbalances

Physiology and Regulation of Antidiuretic Hormone (ADH)

Antidiuretic Hormone, or ADH, is a critical regulator of water balance. It is synthesized by the hypothalamus and stored/released by the hypophysis (pituitary gland). The secretion of ADH is primarily triggered by two physiological stimuli: a state of hypovolemia (decreased blood volume) or hyperosmolality (increased concentration of solutes in the blood). Once released into the bloodstream, its half-life is notably short, lasting only a few minutes.

Mechanistically, ADH functions by binding to the V2 receptor (V2R). These receptors are specifically located on the basolateral pole of the cells within the renal collecting tube. Upon activation, ADH stimulates water retention by increasing the permeability of the collecting tube to water, thereby decreasing urine volume and concentrating the urine. In pathology, certain conditions can involve inappropriate secretion of this hormone, leading to significant electrolyte imbalances.

Syndrome of Inappropriate Antidiuretic Hormone (SIADH)

The Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH) is characterized by an excessive release of ADH regardless of plasma osmolality or volume status. The diagnostic criteria for SIADH are specific and require the exclusion of other pathologies. Clinically, the patient must be in a state of euvolemia, meaning there are no signs of extracellular dehydration (DEC) or overhydration (HEC). Biologically, SIADH presents with a low plasma osmolality, typically documented as less than $275\,mOsm/kg$ (or less than $270\,mOsm/kg$ depending on the specific threshold used in case evaluations).

Other essential diagnostic criteria include the presence of normal renal function and normal adrenal function. Furthermore, the absence of hypothyroidism must be confirmed, as this condition can mimic the hyponatremic state of SIADH. Historically and academically, the absence of hyperthyroidism is also noted in discussions of SIADH criteria, though the primary focus remains on adrenocortical and thyroid sufficiency. Common etiologies for SIADH include central nervous system (SNC) infections, intracranial trauma, pulmonary infections (infectious pneumopathy), and mechanical ventilation.

Diagnosis and Biological Investigation of Hyponatremia

The diagnostic approach to hyponatremia must be systematic. The investigation begins with the calculation of plasma osmolality to distinguish between true hyponatremia and pseudohyponatremia. Assessment of the extracellular compartment (extracellular volume status) is the next vital step, followed by the measurement of natriuresis (urinary sodium levels) and urinary osmolality. These markers help determine if the sodium loss is renal or extra-renal and whether the kidneys' ability to dilute urine is intact.

Distinguishing "false" hyponatremia (pseudohyponatremia) is crucial for avoiding unnecessary treatment. Common causes of pseudohyponatremia include hyperlipidemia and hyperproteinemia, which interfere with certain laboratory measurement techniques. Additionally, hyperglycemia can cause a translocational hyponatremia where water moves from the intracellular to the extracellular space to balance osmotic pressure. Other biological markers often requested in the etiological workup include blood glucose (glycémie), protein levels (protidémie), and blood urea.

Clinical Features of Extra- and Intracellular Hydration Disorders

Extracellular hydration disorders are primarily characterized by changes in the skin and cardiovascular status. Extracellular Dehydration (DEC) presents with signs such as a skin fold (pli cutané), weight loss, and intense thirst. Biologically, DEC leads to hemoconcentration, manifested as hyperproteinemia and an elevated hematocrit level. It may also result in functional renal failure (insuffisance rénale fonctionnelle) and a low central venous pressure (PVC basse). In contrast, Extracellular Overhydration (HEC) is marked by edema (specifically dependent or "déclive" edema), arterial hypertension (HTN), and the presence of pulmonary crackles (râles crépitants) upon auscultation. Common causes of HEC include cardiac failure, liver cirrhosis, nephritic syndrome, pregnancy, and severe malnutrition.

Intracellular hydration disorders reflect the state of cellular swelling or shrinkage. Pure Intracellular Dehydration (DIC) is secondary to a loss of pure water or a gain of salt, leading to hypernatremia (natremia > 145\,mmol/l) and plasma hyperosmolality (typically > 305\,mOsm/kg). Clinical signs of DIC include thirst, fever, and neurological symptoms such as seizures (crises convulsives) or consciousness disorders. Conversely, Intracellular Overhydration (HIC) is secondary to pure water retention or a gain of water exceeding salt gain. This results in hyponatremia and can be caused by potomania, massive infusion of hypotonic solutes, SIADH, or acute adrenal insufficiency. Severity signs for hyponatremia (indicating significant HIC) include vomiting, somnolence, and convulsions, whereas milder symptoms include headaches and nausea.

Treatment and Management of Hyponatremia

The management of acute or severe hyponatremia is a medical priority. In severe cases, symptomatic treatment should be initiated immediately, even before the etiological investigation is complete. The overarching goal is the safe and controlled elevation of plasma sodium levels. For acute and symptomatic hyponatremia, current protocols suggest increasing the natremia by $5\,mmol/l$ within the first hour. However, it is imperative not to exceed an increase of $10\,mmol/l$ within the first 24 hours. The clinical objective is often set to reach a natremia of $125\,mmol/l$ within 24 hours, with full normalization targeted between 48 and 72 hours.

Correction must be slow and prudent, as rapid correction of hyponatremia carries the risk of severe neurological damage. Specifically, a correction rate of $1\,to\,2\,mmol/l$ per hour is recommended until symptoms improve. While isotonic saline (SSI) is often used for initial correction, its use should be reassessed upon clinical improvement. In cases of chronic hyponatremia, slow correction is particularly vital to prevent complications.

Central Pontine Myelinolysis (CPM)

Central Pontine Myelinolysis is a grave neurological complication resulting from the rapid correction of hyponatremia. The condition involves the destruction of oligodendrocytes and the myelin sheath in the central part of the pons (protubérance), though it can also involve the thalamus. Clinically, it can manifest as an extrapyramidal syndrome and other severe neurological deficits. Lesions associated with CPM are not always easily identifiable on a standard CT scan, often requiring MRI for confirmation. The prognosis of CPM is frequently somber, although it may be partially reversible with rapid and adequate specialized management. It is noted that certain populations, such as diabetics, may have altered risks, but the primary driver remains the rate of sodium correction.

Clinical Case Analysis

Case Study 1: Patient AR, a 68-year-old smoker and chronic alcoholic, presented with hemoptysis and a weight loss (cachectic), but no signs of extracellular dehydration. Laboratory results showed a natremia of $128\,mmol/l$, urea at $4\,mmol/l$, creatinine at $60\,\mu mol/l$, blood glucose at $5\,mmol/l$, and protein levels at $62\,g/l$. A chest X-ray revealed a right hilar opacity with irregular contours. This profile suggests a pure Intracellular Overhydration (HIC) secondary to SIADH, likely a paraneoplastic manifestation of lung cancer. Management involves fluid restriction (restriction hydrique) and treatment of the underlying cause.

Case Study 2: Mr. X, a 42-year-old with heavy alcohol use, presented with lethargy, confusion, jaundice, and ascites. Vital signs were stable (BP $130/70\,mmHg$, heart rate $80\,bpm$). Laboratory findings revealed severe hyponatremia (Na+: $108\,mmol/l$), plasma osmolality of $228\,mOsm/kg$, and low urinary sodium ($12\,mmol/l$). The most probable cause for this hyponatremia is liver cirrhosis (cirrhose hépatique). The recommended treatment is a slow, controlled correction of the natremia.

Case Study 3: Patient ML, a 56-year-old with a pituitary tumor, presented with polyuria and delirium. Clinical examination found dry mucous membranes. Laboratory results showed severe hypernatremia (Na+: $164\,mmol/l$), elevated blood glucose ($8\,mmol/l$), and very low urinary osmolality ($59\,mOsm/kg$). This presentation is characteristic of Intracellular Dehydration (DIC), likely due to central diabetes insipidus resulting from the pituitary tumor.

Questions & Discussion

Q: What are the criteria for SIADH? A: The criteria include plasma osmolality < 275\,mOsm/kg, clinical euvolemia, normal renal and adrenal functions, and the absence of hypothyroidism.

Q: What is the risk of correcting hyponatremia too quickly? A: The primary risk is Central Pontine Myelinolysis (CPM), a severe neurological condition.

Q: What signs indicate Extracellular Overhydration (HEC)? A: Key signs include dependent edema, hypertension, and pulmonary crackles.

Q: In the case of acute hyponatremia, what is the initial management goal? A: The goal is to start symptomatic treatment immediately and aim for an increase in natremia of about $5\,mmol/l$ in the first hour, ensuring not to exceed $10\,mmol/l$ in the first day.